These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26364134)

  • 1. Influenza virus-host interactomes as a basis for antiviral drug development.
    Watanabe T; Kawaoka Y
    Curr Opin Virol; 2015 Oct; 14():71-8. PubMed ID: 26364134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
    Ludwig S
    Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The host interactome of influenza virus presents new potential targets for antiviral drugs.
    Shaw ML
    Rev Med Virol; 2011 Nov; 21(6):358-69. PubMed ID: 21823192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.
    Beyleveld G; White KM; Ayllon J; Shaw ML
    Antiviral Res; 2013 Oct; 100(1):120-32. PubMed ID: 23933115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-Guided Discovery of Influenza Virus Replication Host Factors.
    Ackerman EE; Kawakami E; Katoh M; Watanabe T; Watanabe S; Tomita Y; Lopes TJ; Matsuoka Y; Kitano H; Shoemaker JE; Kawaoka Y
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections.
    van de Wakker SI; Fischer MJE; Oosting RS
    Eur J Pharmacol; 2017 Aug; 809():178-190. PubMed ID: 28533172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular networks involved in the influenza virus life cycle.
    Watanabe T; Watanabe S; Kawaoka Y
    Cell Host Microbe; 2010 Jun; 7(6):427-39. PubMed ID: 20542247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.
    de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
    Mol Biosyst; 2012 Apr; 8(4):1297-303. PubMed ID: 22307679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.
    Lee SM; Yen HL
    Antiviral Res; 2012 Dec; 96(3):391-404. PubMed ID: 23022351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus-host interactome screen as a platform for antiviral drug development.
    Watanabe T; Kawakami E; Shoemaker JE; Lopes TJ; Matsuoka Y; Tomita Y; Kozuka-Hata H; Gorai T; Kuwahara T; Takeda E; Nagata A; Takano R; Kiso M; Yamashita M; Sakai-Tagawa Y; Katsura H; Nonaka N; Fujii H; Fujii K; Sugita Y; Noda T; Goto H; Fukuyama S; Watanabe S; Neumann G; Oyama M; Kitano H; Kawaoka Y
    Cell Host Microbe; 2014 Dec; 16(6):795-805. PubMed ID: 25464832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology of influenza: understanding multidimensional interactions for personalized prevention and treatment.
    Yan Q
    Methods Mol Biol; 2010; 662():285-302. PubMed ID: 20824477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Effects of Influenza Antiviral Drugs.
    Yin H; Jiang N; Shi W; Chi X; Liu S; Chen JL; Wang S
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33557246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
    Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
    Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
    Eichelberger MC; Hassantoufighi A; Wu M; Li M
    Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of interferon inducible trans-membrane proteins and retinoic acid inducible gene I for influenza virus replication: A review.
    Suo S; Ren X
    Crit Rev Microbiol; 2016; 42(1):75-82. PubMed ID: 25811941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of cellular signaling pathway inhibitors as new antivirals against influenza.
    Planz O
    Antiviral Res; 2013 Jun; 98(3):457-68. PubMed ID: 23603495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Activity of Aspalathus linearis against Human Influenza Virus.
    Rahmasaria R; Haruyama T; Charyasriwong S; Nishida T; Kobayashi N
    Nat Prod Commun; 2017 Apr; 12(4):599-602. PubMed ID: 30520604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.